Withdrawn | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications 1 that have been subsequently withdrawn, and are therefore, no longer FDA-approved. Please refer to Drugs@FDA for the latest approvals and prescribing information for specific products. Visit the ongoing or verified AA indication pages for more information.
Withdrawn indications are not listed until FDA publishes a Federal Register notice to that effect or updates product labeling.
- 1. Each unique oncology indication-product pairing is listed individually (this database excludes supportive care products and changes to dosing or formulation).
- 2. Withdrawal date indicates either the effective date published by the Federal Register or the date the product label was updated, whichever date came first.